Inherited erythermalgia: Limb pain from an S4 charge-neutral Na channelopathy

Neurology

Volumn 67, Issue 9, 2006, Pages 1563-1567

  Choi, Jin Sung ^b   Dib Hajj, Sulayman D ^b   Waxman, Stephen G ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; EMBRYO; ERYTHROMELALGIA; GENE EXPRESSION; GENE MUTATION; GENETIC LINKAGE; HERITABILITY; HUMAN; HUMAN CELL; LIMB PAIN; MAMMAL CELL; MEMBRANE DEPOLARIZATION; NOCICEPTIVE RECEPTOR; PATCH CLAMP; PRIORITY JOURNAL; SKIN BURNING SENSATION; WHOLE CELL; WILD TYPE;

ACTION POTENTIALS; CELL LINE; CELL MEMBRANE; ERYTHROMELALGIA; EXTREMITIES; GANGLIA, SPINAL; HUMANS; MEMBRANE POTENTIALS; MUTATION; NEURAL CONDUCTION; NEURONS, AFFERENT; NOCICEPTORS; PAIN; PATCH-CLAMP TECHNIQUES; PROTEIN SUBUNITS; SODIUM CHANNELS;

EID: 33750976383     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000231514.33603.1e     Document Type: Article

References (22)

1. Waxman SG, Dib-Hajj S. Erythermalgia: molecular basis for an inherited pain syndrome. Trends Mol Med 2005;11:555-562.
2. Yang Y, Wang Y, Li S, et al. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia. J Med Genet 2004;41:171-174.
3. Dib-Hajj SD, Rush AM, Cummins TR, et al. Gain-of-function mutation in Nav1.7 in familial erythromelalgia induces bursting of sensory neurons. Brain 2005;128:1847-1854.
4. Drenth JP, Te Morsche RH, Guillet G, Taieb A, Kirby RL, Jansen JB. SCN9A mutations define primary erythermalgia as a neuropathic disorder of voltage gated sodium channels. J Invest Dermatol 2005;124:1333-1338.
5. Michiels JJ, te Morsche RH, Jansen JB, Drenth JP. Autosomal dominant erythermalgia associated with a novel mutation in the voltage-gated sodium channel alpha subunit Nav1.7. Arch Neurol 2005;62:1587-1590.
6. Han C, Rush AM, Dib-Hajj SD, et al. Sporadic onset of erythermalgia: a gain-of-function mutation in Nav1.7. Ann Neurol 2006;59:553-558.
7. Cummins TR, Dib-Hajj SD, Waxman SG. Electrophysiological properties of mutant Nav1.7 sodium channels in a painful inherited neuropathy. J Neurosci 2004;24:8232-8236.
8. Drenth JP, Michiels JJ. Erythromelalgia and erythermalgia: diagnostic differentiation. Int J Dermatol 1994;33:393-397.
9. Lossin C, Wang DW, Rhodes TH, Vanoye CG, George AL Jr. Molecular basis of an inherited epilepsy. Neuron 2002;34:877-884.
10. Catterall WA. From ionic currents to molecular mechanisms: the structure and function of voltage-gated sodium channels. Neuron 2000;26:13-25.
11. Caffrey JM, Eng DL, Black JA, Waxman SG, Kocsis JD. Three types of sodium channels in adult rat dorsal root ganglion neurons. Brain Res 1992;592:283-297.
12. Harper AA, Lawson SN. Electrical properties of rat dorsal root ganglion neurones with different peripheral nerve conduction velocities. J Physiol (Lond) 1985;359:47-63.
13. Auld VJ, Goldin AL, Krafte DS, et al. A neutral amino acid change in segment IIS4 dramatically alters the gating properties of the voltage-dependent sodium channel. Proc Natl Acad Sci USA 1990;87:323-327.
14. Cannon SC. From mutation to myotonia in sodium channel disorders. Neuromusc Disord 1997;7:241-249.
15. Olson TM, Michels VV, Ballew JD, et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 2005;293:447-454.
16. Bezanilla F. The voltage sensor in voltage-dependent ion channels. Physiol Rev 2000;80:555-592.
17. Bezzina CR, Rook MB, Groenewegen WA, et al. Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system. Circ Res 2003;92:159-168.
18. Kuhnert SM, Phillips WJ, Davis MD. Lidocaine and mexiletine therapy for erythromelalgia. Arch Dermatol 1999;135:1447-1449.
19. Legroux-Crespel E, Sassolas B, Guillet G, Kupfer I, Dupre D, Misery L. Treatment of familial erythermalgia with the association of lidocaine and mexiletine. Ann Dermatol Venereol 2003;130:429-433.
20. Jang HS, Jung D, Kim S, et al. A case of primary erythromelalgia improved by mexiletine. Br J Dermatol 2004;151:708-710.
21. Nathan A, Rose JB, Guite JW, Hehir D, Milovcich K. Primary erythromelalgia in a child responding to intravenous lidocaine and oral mexiletine treatment. Pediatrics 2005;115:e504-e507.
22. Yeomans DC, Levinson SR, Peters MC, et al. Decrease in inflammatory hyperalgesia by herpes vector-mediated knockdown of Na(v)1.7 sodium channels in primary afferents. Hum Gene Ther 2005;16:271-277.